• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Theravance

Theravance

  1. Innoviva to Report First Quarter Financial Results on July 26 at 5:00 p.m. EDT

    Innoviva to Report First Quarter Financial Results on July 26 at 5:00 p.m. EDT

  2. Global Antibiotics Analysis and Forecasts 2017-2022: The Quest for New Super Drugs - Technologies, Markets, Competitors and Opportunities - Research and Markets

    Global Antibiotics Analysis and Forecasts 2017-2022: The Quest for New Super Drugs - Technologies, Markets, Competitors and Opportunities - Research and Markets

  3. Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) Pipeline Report, H1 2017 - Therapeutics Review of 18 Companies & Drug Profiles - Research and Markets

    Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) Pipeline Report, H1 2017 - Therapeutics Review of 18 Companies & Drug Profiles - Research and Markets

1

©2017 Morningstar Advisor. All right reserved.